277 related articles for article (PubMed ID: 32324152)
1. Glycan-specific antibodies as potential cancer biomarkers: a focus on microarray applications.
Tikhonov A; Smoldovskaya O; Feyzkhanova G; Kushlinskii N; Rubina A
Clin Chem Lab Med; 2020 Sep; 58(10):1611-1622. PubMed ID: 32324152
[TBL] [Abstract][Full Text] [Related]
2. Overview of Characterizing Cancer Glycans with Lectin-Based Analytical Methods.
Pearson AJ; Gallagher ES
Methods Mol Biol; 2019; 1928():389-408. PubMed ID: 30725466
[TBL] [Abstract][Full Text] [Related]
3. Multiplexed analysis of glycan variation on native proteins captured by antibody microarrays.
Chen S; LaRoche T; Hamelinck D; Bergsma D; Brenner D; Simeone D; Brand RE; Haab BB
Nat Methods; 2007 May; 4(5):437-44. PubMed ID: 17417647
[TBL] [Abstract][Full Text] [Related]
4. [Application of glycan microarrays in cancer research].
Xu B; Liu Y; Xie Y
Sheng Wu Gong Cheng Xue Bao; 2020 Nov; 36(11):2313-2326. PubMed ID: 33244926
[TBL] [Abstract][Full Text] [Related]
5. Antibodies against aberrant glycans as cancer biomarkers.
Blsakova A; Kveton F; Kasak P; Tkac J
Expert Rev Mol Diagn; 2019 Dec; 19(12):1057-1068. PubMed ID: 31665948
[No Abstract] [Full Text] [Related]
6. Microbe-focused glycan array screening platform.
Geissner A; Reinhardt A; Rademacher C; Johannssen T; Monteiro J; Lepenies B; Thépaut M; Fieschi F; Mrázková J; Wimmerova M; Schuhmacher F; Götze S; Grünstein D; Guo X; Hahm HS; Kandasamy J; Leonori D; Martin CE; Parameswarappa SG; Pasari S; Schlegel MK; Tanaka H; Xiao G; Yang Y; Pereira CL; Anish C; Seeberger PH
Proc Natl Acad Sci U S A; 2019 Feb; 116(6):1958-1967. PubMed ID: 30670663
[TBL] [Abstract][Full Text] [Related]
7. Serum antibody screening by surface plasmon resonance using a natural glycan microarray.
de Boer AR; Hokke CH; Deelder AM; Wuhrer M
Glycoconj J; 2008 Jan; 25(1):75-84. PubMed ID: 18193481
[TBL] [Abstract][Full Text] [Related]
8. Glycan microarrays: powerful tools for biomarker discovery.
Muthana SM; Gildersleeve JC
Cancer Biomark; 2014 Jan; 14(1):29-41. PubMed ID: 24643040
[TBL] [Abstract][Full Text] [Related]
9. Chemically-blocked antibody microarray for multiplexed high-throughput profiling of specific protein glycosylation in complex samples.
Lu C; Wonsidler JL; Li J; Du Y; Block T; Haab B; Chen S
J Vis Exp; 2012 May; (63):e3791. PubMed ID: 22588202
[TBL] [Abstract][Full Text] [Related]
10. Altered glycosylation in cancer: A promising target for biomarkers and therapeutics.
Thomas D; Rathinavel AK; Radhakrishnan P
Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188464. PubMed ID: 33157161
[TBL] [Abstract][Full Text] [Related]
11. Application of microarrays for deciphering the structure and function of the human glycome.
Smith DF; Cummings RD
Mol Cell Proteomics; 2013 Apr; 12(4):902-12. PubMed ID: 23412570
[TBL] [Abstract][Full Text] [Related]
12. Carbohydrate microarrays for enzymatic reactions and quantification of binding affinities for glycan-protein interactions.
Lee MR; Park S; Shin I
Methods Mol Biol; 2012; 808():103-16. PubMed ID: 22057520
[TBL] [Abstract][Full Text] [Related]
13. Serum antibodies to blood group A predict survival on PROSTVAC-VF.
Campbell CT; Gulley JL; Oyelaran O; Hodge JW; Schlom J; Gildersleeve JC
Clin Cancer Res; 2013 Mar; 19(5):1290-9. PubMed ID: 23362327
[TBL] [Abstract][Full Text] [Related]
14. Quantitative O-glycomics based on improvement of the one-pot method for nonreductive O-glycan release and simultaneous stable isotope labeling with 1-(d
Wang C; Zhang P; Jin W; Li L; Qiang S; Zhang Y; Huang L; Wang Z
J Proteomics; 2017 Jan; 150():18-30. PubMed ID: 27585995
[TBL] [Abstract][Full Text] [Related]
15. Application of Lectin Microarrays for Biomarker Discovery.
Dang K; Zhang W; Jiang S; Lin X; Qian A
ChemistryOpen; 2020 Mar; 9(3):285-300. PubMed ID: 32154049
[TBL] [Abstract][Full Text] [Related]
16. Serum antibody screening using glycan arrays.
Marglous S; Brown CE; Padler-Karavani V; Cummings RD; Gildersleeve JC
Chem Soc Rev; 2024 Mar; 53(5):2603-2642. PubMed ID: 38305761
[TBL] [Abstract][Full Text] [Related]
17. Aberrant glycosylation as biomarker for cancer: focus on CD43.
Tuccillo FM; de Laurentiis A; Palmieri C; Fiume G; Bonelli P; Borrelli A; Tassone P; Scala I; Buonaguro FM; Quinto I; Scala G
Biomed Res Int; 2014; 2014():742831. PubMed ID: 24689054
[TBL] [Abstract][Full Text] [Related]
18. Glycans as cancer biomarkers.
Adamczyk B; Tharmalingam T; Rudd PM
Biochim Biophys Acta; 2012 Sep; 1820(9):1347-53. PubMed ID: 22178561
[TBL] [Abstract][Full Text] [Related]
19. Isomer-specific profiling of N-glycans derived from human serum for potential biomarker discovery in pancreatic cancer.
Liu Y; Wang C; Wang R; Wu Y; Zhang L; Liu BF; Cheng L; Liu X
J Proteomics; 2018 Jun; 181():160-169. PubMed ID: 29674015
[TBL] [Abstract][Full Text] [Related]
20. Human disease glycomics: technology advances enabling protein glycosylation analysis - part 1.
Everest-Dass AV; Moh ESX; Ashwood C; Shathili AMM; Packer NH
Expert Rev Proteomics; 2018 Feb; 15(2):165-182. PubMed ID: 29285957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
